Dystromirs as Serum Biomarkers for Monitoring the Disease Severity in Duchenne Muscular Dystrophy
Page 1 of 1
Dystromirs as Serum Biomarkers for Monitoring the Disease Severity in Duchenne Muscular Dystrophy
Zaharieva IT, Calissano M, Scoto M, Preston M, Cirak S, Feng L, Collins J, Kole R, Guglieri M, Straub V, Bushby K, Ferlini A, Morgan JE, Muntoni F. Dystromirs as Serum Biomarkers for Monitoring the Disease Severity in Duchenne Muscular Dystrophy. PLoS ONE. 2013;8(11):e80263. doi:10.1371/journal.pone.0080263
Similar topics
» Identification of novel, therapy-responsive protein biomarkers in a mouse model of Duchenne muscular dystrophy by aptamer-based serum proteomics
» Eteplirsen for the treatment of duchenne muscular dystrophy
» Challenges to oligonucleotides-based therapeutics for Duchenne muscular dystrophy
» Exon-skipping therapy for Duchenne muscular dystrophy
» Exon skipping approach to duchenne muscular dystrophy
» Eteplirsen for the treatment of duchenne muscular dystrophy
» Challenges to oligonucleotides-based therapeutics for Duchenne muscular dystrophy
» Exon-skipping therapy for Duchenne muscular dystrophy
» Exon skipping approach to duchenne muscular dystrophy
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum
|
|